InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the complete record of transactions filed by Plesha Scott M., 首席执行官. Officer active across 2 companies, notably Pelthos Therapeutics Inc.. Aggregated, 3 filings have been logged. History available since 27 January 2022. The latest transaction was disclosed on 2 July 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Scott M. Plesha is the CEO and President of Pelthos Therapeutics Inc. and BioDelivery Sciences International Inc. In these roles, he is responsible for the strategic and operational direction of the companies, which focus on developing innovative therapies. Mr. Plesha plays a crucial role in setting growth objectives and overseeing daily operations.